Related Experiment Video
Updated: Oct 2, 2025
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
83.9K
Treatment of Atypical Clots
1Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Hamostaseologie
|February 23, 2022
Summary
Unusual site thrombosis, affecting veins beyond the legs and pulmonary arteries, requires tailored antithrombotic therapy. Direct oral anticoagulants show promise for upper limb, cerebral, and splanchnic vein thrombosis.
Area of Science:
- Vascular Medicine
- Hematology
- Thrombosis Research
Background:
- Unusual site thrombosis involves venous thromboembolism outside typical lower limb and pulmonary locations.
- Common affected sites include upper limb, retinal, splanchnic, and cerebral veins.
- Clinical presentations and predisposing factors vary across these unusual venous segments.
Purpose of the Study:
- To review the current evidence on treating venous thrombosis in unusual sites.
- To discuss the role of antithrombotic therapies, including direct oral anticoagulants, in managing these conditions.
Main Methods:
- Systematic review of existing literature on unusual site thrombosis treatment.
- Analysis of clinical trial data and observational studies.
- Evaluation of treatment guidelines and expert consensus.
Main Results:
- Antithrombotic therapy is standard, but treatment specifics (type, intensity, duration) differ significantly.
- Direct oral anticoagulants are increasingly supported for upper limb deep vein thrombosis, cerebral vein thrombosis, and splanchnic vein thrombosis.
- Evidence for other unusual sites and anticoagulation strategies is still evolving.
Conclusions:
- Management of unusual site thrombosis necessitates individualized treatment approaches.
- Direct oral anticoagulants represent a significant advancement in treating specific unusual venous thromboembolism cases.
- Further research is needed to optimize therapeutic strategies for all unusual thrombosis locations.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
43
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
43
01:16Clot Retraction and Fibrinolysis
7.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.2K
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
60
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
60
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
972
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
972
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.4K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.4K
01:27Peripheral Artery Disease III: Interprofessional Care
44
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
44